Cost considerations in the treatment of oropharyngeal squamous cell carcinoma

Eric J. Moore, Michael L. Hinni, Kerry D. Olsen, Daniel L. Price, Rebecca R. Laborde, Jared C. Inman

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

Objectives. To determine the cost of treatment of oropharyngeal squamous cell carcinoma (OP SCCA) with transoral surgery with concomitant neck dissection (TOS), TOS with adjuvant radiation therapy (TOS + RT), TOS with adjuvant chemoradiation therapy (TOS + CRT), and primary chemoradiation therapy (CRT).Study Design. Case series.Setting. Two tertiary care teaching hospitals.Subjects and Methods. Using the databases of 2 teaching hospitals, patients were identified who had OP SCCA treated with TOS, TOS + RT, TOS + CRT, and primary CRT in 2009 to 2010. Costs were analyzed from an institutional perspective looking at reimbursement. Patients with government payers and patients with private payers in each group were identified, and net revenue data obtained for the 3-month period from diagnosis were calculated and averaged for each group. Cost was defined as the reimbursement for all charges surrounding the 3-month episode of treatment. All revenue associated with inpatient and outpatient care, including pharmacy charges, was included.Results. The mean cost of TOS (private payers/government payers) was $37,435/$15,664 (range, $22,486-$48,746/$13,325-$16,885). The mean cost of TOS + RT (private payers/government payers) was $74,484/ $34,343 (range, $72,400-$84,825/$31,565-$40, 810). The mean cost of TOS + CRT (private payers/government payers) was $191,780/$53,245 (range, $145,450-$217,220/ $49,400-$58,325). The mean cost of CRT (private payers/government payers) was $198,285/$57,429 (range, $168,216-$298, 945/$52,900-$59,545).Conclusion. An algorithm of transoral surgical treatment of OP SCCA with adjuvant treatment as indicated by pathology is more cost conscious than an algorithm of treatment of all OP SCCA with CRT.

Original languageEnglish (US)
Pages (from-to)946-951
Number of pages6
JournalOtolaryngology - Head and Neck Surgery (United States)
Volume146
Issue number6
DOIs
StatePublished - Jun 1 2012

Keywords

  • cost
  • head and neck squamous cell carcinoma
  • oropharyngeal cancer

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Cost considerations in the treatment of oropharyngeal squamous cell carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Moore, E. J., Hinni, M. L., Olsen, K. D., Price, D. L., Laborde, R. R., & Inman, J. C. (2012). Cost considerations in the treatment of oropharyngeal squamous cell carcinoma. Otolaryngology - Head and Neck Surgery (United States), 146(6), 946-951. https://doi.org/10.1177/0194599812437534